CP
MRNA icon

Corbenic Partners’s Moderna MRNA Stock Holding History

Corbenic Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$8K Hold
55
– – ﹤0.01% 134
2022
Q1 		$9K Sell
55
-9
-14% -$1.51K ﹤0.01% 154
2021
Q4 		$16K Hold
64
– – ﹤0.01% 139
2021
Q3 		$25K Buy
+64
New +$23.6K 0.01% 105
2020
Q3 		– Sell
-500
Closed -$32K – 173
2020
Q2 		$32K Buy
+500
New +$27.4K 0.02% 74

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corbenic Partners's MRNA Position: Q2 2022 in Review

Corbenic Partners held its Moderna (MRNA) position steady in Q2 2022 at 55 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #134.

Corbenic Partners first reported a position in MRNA in Q2 2020 and has held it in 5 quarters since. The position peaked at $32K in Q2 2020. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Corbenic Partners held 55 shares of Moderna worth $8K as of Q2 2022.
  • Corbenic Partners left its Moderna share count unchanged in Q2 2022.
  • Moderna made up ﹤0.01% of Corbenic Partners's portfolio in Q2 2022, its #134 holding.
  • Corbenic Partners first reported a position in Moderna in Q2 2020 and has held it in 5 quarters since.
  • Corbenic Partners's Moderna position peaked at $32K in Q2 2020.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Corbenic Partners's 13F filing for Q2 2022, filed 25 Jul 2022.